Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

516 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours.
Iacovazzo D, Chiloiro S, Carlsen E, Bianchi A, Giampietro A, Tartaglione T, Bima C, Bracaccia ME, Lugli F, Lauretti L, Anile C, Gessi M, Colosimo C, Rindi G, Pontecorvi A, Korbonits M, De Marinis L. Iacovazzo D, et al. Among authors: rindi g. Endocrine. 2020 Mar;67(3):651-658. doi: 10.1007/s12020-019-02145-y. Epub 2019 Dec 24. Endocrine. 2020. PMID: 31875303 Free PMC article.
CD68+ and CD8+ immune cells are associated with the growth pattern of somatotroph tumors and response to first generation somatostatin analogs.
Chiloiro S, Giampietro A, Gessi M, Lauretti L, Mattogno PP, Cerroni L, Carlino A, De Alessandris QG, Olivi A, Rindi G, Pontecorvi A, De Marinis L, Doglietto F, Bianchi A. Chiloiro S, et al. Among authors: rindi g. J Neuroendocrinol. 2023 Apr;35(4):e13263. doi: 10.1111/jne.13263. Epub 2023 Apr 20. J Neuroendocrinol. 2023. PMID: 37078422
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response.
Chiloiro S, Giampietro A, Mirra F, Donfrancesco F, Tartaglione T, Mattogno PP, Angelini F, Liverana L, Gessi M, Carmelo A, Rindi G, Giustina A, Fleseriu M, Pontecorvi A, De Marinis L, Bianchi A. Chiloiro S, et al. Among authors: rindi g. Eur J Endocrinol. 2021 Feb;184(2):217-229. doi: 10.1530/EJE-20-0767. Eur J Endocrinol. 2021. PMID: 33136550
The Multibiomarker Acro-TIME Score Predicts fg-SRLs Response: Preliminary Results of a Retrospective Acromegaly Cohort.
Chiloiro S, Moroni R, Giampietro A, Angelini F, Gessi M, Lauretti L, Mattogno PP, Calandrelli R, Tartaglione T, Carlino A, Gaudino S, Olivi A, Rindi G, De Marinis L, Pontecorvi A, Doglietto F, Bianchi A. Chiloiro S, et al. Among authors: rindi g. J Clin Endocrinol Metab. 2024 Apr 19;109(5):1341-1350. doi: 10.1210/clinem/dgad673. J Clin Endocrinol Metab. 2024. PMID: 37975821
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review.
Chiloiro S, Bianchi A, Doglietto F, de Waure C, Giampietro A, Fusco A, Iacovazzo D, Tartaglione L, Di Nardo F, Signorelli F, Lauriola L, Anile C, Rindi G, Maira G, Pontecorvi A, De Marinis L. Chiloiro S, et al. Among authors: rindi g. Pituitary. 2014 Jun;17(3):267-76. doi: 10.1007/s11102-013-0500-6. Pituitary. 2014. PMID: 23828322 Review.
Gene Expression Profiling of Pancreas Neuroendocrine Tumors with Different Ki67-Based Grades.
Simbolo M, Bilotta M, Mafficini A, Luchini C, Furlan D, Inzani F, Petrone G, Bonvissuto D, La Rosa S, Schinzari G, Bianchi A, Rossi E, Menghi R, Giuliante F, Boccia S, Scarpa A, Rindi G. Simbolo M, et al. Among authors: rindi g. Cancers (Basel). 2021 Apr 23;13(9):2054. doi: 10.3390/cancers13092054. Cancers (Basel). 2021. PMID: 33922803 Free PMC article.
516 results